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Abstract
Background: Recent studies provide evidence for the effectiveness of Internet-based maintenance treatments for mental disorders.
However, it is still unclear which participants might or might not profit from this particular kind of treatment delivery.
Objective: The study aimed to identify moderators of treatment outcome in a transdiagnostic Internet-based maintenance
treatment (TIMT) offered to patients after inpatient psychotherapy for mental disorders in routine care.
Methods: Using data from a randomized controlled trial (N=400) designed to test the effectiveness of TIMT, we performed
secondary analyses to identify factors moderating the effects of TIMT (intervention) when compared with those of a
treatment-as-usual control condition. TIMT involved an online self-management module, asynchronous patient–therapist
communication, a peer support group, and online-based progress monitoring. Participants in the control condition had unstructured
access to outpatient psychotherapy, standardized outpatient face-to-face continuation treatment, and psychotropic management.
Self-reports of psychopathological symptoms and potential moderators were assessed at the start of inpatient treatment (T1), at
discharge from inpatient treatment/start of TIMT (T2), and at 3-month (T3) and 12-month follow-up (T4).
Results: Education level, positive outcome expectations, and diagnoses significantly moderated intervention versus control
differences regarding changes in outcomes between T2 and T3. Only education level moderated change differences between T2
and T4. The effectiveness of the intervention (vs control) was more pronounced among participants with a low (vs high) education
level (T2-T3: B=–0.32, SE 0.16, P=.049; T2-T4: B=–0.42, SE 0.21, P=.049), participants with high (vs low) positive outcome
expectations (T2-T3: B=–0.12, SE 0.05, P=.02) and participants with anxiety disorder (vs mood disorder) (T2-T3: B=–0.43, SE
0.21, P=.04). Simple slope analyses revealed that despite some subgroups benefiting less from the intervention than others, all
subgroups still benefited significantly.
Conclusions: This transdiagnostic Internet-based maintenance treatment might be suitable for a wide range of participants
differing in various clinical, motivational, and demographic characteristics. The treatment is especially effective for participants
with low education levels. These findings may generalize to other Internet-based maintenance treatments.
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Introduction
Despite strong evidence for the efficacy of psychotherapy for
common mental health disorders [1,2], long-term outcome of
psychotherapeutic interventions are still a major concern [3-6].
Psychological treatments following acute phase psychotherapy
that aim to maintain achieved changes (ie, maintenance phase
treatments) have been shown to enhance outcome sustainability
(eg, major depressive disorder [7,8], obsessive compulsive
disorder [9], and personality disorders [10,11]). However, such
interventions are difficult to disseminate owing to high
intervention costs and limited clinician availability.
The use of the Internet to provide guided self-help maintenance
phase treatments may help to overcome this unmet maintenance
need. Internet-based guided self-help strategies for the
maintenance phase of psychotherapies have several advantages
over face-to-face maintenance approaches. These include (1)
greater potential for the integration of acquired skills in daily
life because of an emphasis on the patient’s active role in
(guided) self-help treatment [12], (2) elimination of waiting
periods between acute and maintenance treatment, (3)
elimination of travel time and costs for both patients and
clinicians, (4) access to the programs on a 24/7 basis, and (5)
lower costs.
Several studies have shown promising results with delivering
maintenance phase treatments over the Internet [13-20]. For
example, our group developed a form of Internet-based
continuation phase psychotherapy, a transdiagnostic
Internet-based maintenance treatment (TIMT) following
inpatient psychotherapy [15,20]. TIMT was designed to increase
long-term outcomes of inpatients treated in a routine care setting
for common mental health disorders, such as major depressive,
anxiety, posttraumatic stress, obsessive compulsive, eating, or
somatoform disorders. Recently, TIMT was evaluated in a
pragmatic randomized controlled trial (RCT), comparing TIMT
in addition to treatment as usual (TAU) to TAU only (N=400).
In this study, participants in the TIMT plus TAU condition
showed a better maintenance of inpatient treatment effects (ie,
differences in change of psychopathological symptom severity)
from inpatient discharge to 3-month follow-up (between-group
effect size: d=0.38, P<.001) and 12-month follow-up
(between-group effect size: d=0.55, P<.001) than TAU-only
controls [15].
Although there is evidence for the general effectiveness of
Internet-based maintenance phase treatments, little is known
about which patients might or might not benefit from this
particular kind of treatment delivery. Investigating the
moderating effects of patient characteristics on Internet-based
maintenance phase treatment effectiveness is crucial for
identifying appropriate populations and for customizing
interventions to the specific needs of patient subgroups. More
knowledge regarding who is likely or unlikely to profit from
these interventions should also help in identifying relevant
mechanisms of change as well as allocating health care resources
on an evidence-based level [21].
Only a few studies to date have investigated moderators of
Internet-based intervention outcomes for mental health
problems. In 1 of these studies, Warmerdam and colleagues
[22] explored moderators of Internet-based cognitive behavioral
therapy (CBT) and Internet-based problem-solving therapy for
depressive symptoms. None of the variables investigated in this
study (demographic variables, illness severity, dysfunctional
attitudes, and problem-solving skills) moderated the differential
effectiveness of the 2 treatments. In a study comparing the
effects of Internet-based CBT to group-based face-to-face CBT,
Spek et al [23] found that participants high in altruism performed
better in group CBT than in Internet-based CBT (no significant
findings for age, gender, education, neuroticism, extraversion,
agreeableness, openness and conscientiousness, pretreatment
severity, previous episodes of depression, and marital status).
When comparing responses to online CBT for depression
compared to a waitlist control group Button et al [24] found
that higher pretreatment severity of depressive symptoms were
associated with a greater benefit of treatment. In another study,
de Graaf and colleagues [25] explored pretreatment and
short-term improvement variables as moderators of unsupported
Internet-based CBT outcomes, usual primary care (TAU), and
CBT combined with TAU for depression. They found that
patients with higher levels of extreme positive responding to
questionnaires had a better outcome in Internet-based CBT
compared to TAU, whereas those with parental psychiatric
history or with a major depressive disorder diagnosis had a
better outcome in Internet-based CBT plus TAU compared to
TAU.
The aim of the present study was to identify moderating factors
on the effects of TIMT after inpatient psychotherapy. Using
data from a pragmatic RCT on the effectiveness of TIMT
(ISRCTN:28632626) [15], we conducted secondary analyses
to identify demographic, clinical, and motivational variables
that moderate the effects of TIMT on change in
psychopathological symptom severity.
Given the current lack of data on moderators of Internet-based
continuation phase treatment effects, we used an exploratory
approach including a wide range of potential pretreatment
moderators [21]. Our choice of moderators was based on (1)
results of previous studies investigating moderators of
face-to-face continuation treatment outcomes [26,27], (2) results
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of previous predictors/moderators in Internet-based intervention
outcome studies [22,23,25,28,29], (3) predictors of
relapse/long-term outcome studies [5,27,30-36], and (4)
theoretical assumptions attributed to intervention characteristics.
The final list of potential moderators investigated in the present
study included (1) demographics, such as age, gender, education
level, and computer/Internet literacy; (2) clinical characteristics,
such as diagnoses, remission status, age of first onset, comorbid
personality disorder, and reliable change during inpatient
treatment, and (c) motivational variables, such as self-efficacy
and positive outcome expectations.
The primary research questions of this study were:
1. Do any of the pretreatment factors included in this study
moderate the effectiveness of TIMT compared with TAU?
2. If moderating effects are found, do participants
characterized by disadvantageous scores on identified
moderators still benefit from TIMT?
Methods
Study Design
We performed secondary analyses using data from a pragmatic
RCT comparing TIMT in addition to TAU following inpatient
psychotherapy to TAU only (N=400) [15]. The RCT was
conducted in a German clinic providing routine mental health
care. Study outcomes were assessed by using self-report
measures that were completed at inpatient admission (T1), end
of inpatient treatment/beginning of TIMT (T2), 3 months after
discharge/end of TIMT (T3), and 12 months after inpatient
treatment completion (T4). The study was powered to find a
small to moderate effect size in the main effect analyses, which
was considered to be the smallest relevant difference to health
care decision makers in this context. All procedures were
approved by the university and the hospital institutional review
boards. Design and results of the effectiveness trial are described
in detail in a previously published study [15].
Participants and Procedures
We recruited potential participants from 2189 patients treated
for a variety of mental disorders between July 2008 and October
2009 in the study hospital. Patients were eligible for the study
if they (1) were age 18 years or older, (2) met criteria for a
mental disorder according to the International Classification
of Diseases, Tenth Revision (ICD-10) [37], (3) spoke German
sufficiently, (4) had basic reading and writing skills, and (5)
had access to a computer with an Internet connection. Exclusion
criteria were (1) a psychotic diagnosis, (2) acute alcohol or
substance dependence, and (3) a significant risk for suicide.
Participants who gave full written informed consent were
randomly assigned to receive TAU only (control) or TAU plus
TIMT (intervention). In total, 58 of 400 (14.5%) participants
did not complete the T3 assessment and 113 (28.5%) did not
complete the T4 assessment. Participants who did not provide
data at 1 of the follow-ups did not differ from participants
without missing data on baseline psychopathological symptom
severity scores or any other clinical characteristics (all P values
>.10), except for age (noncompleters on average 2.21 years
younger than completers, P=.02). No significant interactions
were found between missing pattern and outcome using pattern
mixture analyses [38]. Thus, missing data appear not to bias the
results. Figure 1 summarizes participant enrollment and flow
throughout the study [15].
Interventions
Inpatient Treatment
Inpatient treatment was based on CBT [39]. Participants received
1 session of individual therapy (50 minutes) and an average of
6 sessions of group therapy (90 minutes) per week. Interventions
were supplemented with sports therapy and physiotherapy, as
well as medical treatment (including pharmacotherapy) when
necessary. Treatment was delivered by 6 experienced therapists
and 14 therapists in training. Duration of treatment ranged
between 22 and 98 days (mean 46.30, SD 8.17).
Treatment as Usual Condition
Following inpatient treatment, all participants had unstructured
access to outpatient psychotherapy and standardized outpatient
group-based, face-to-face, maintenance treatment [40] as
typically provided by the referring agencies. In addition, there
was no restriction on the use of medication during the study
period.
Treatment as Usual Plus Transdiagnostic Internet-Based
Maintenance Treatment Condition
In addition to TAU, the intervention group had TIMT for 12
weeks. The main focus of TIMT is to support patients in the
sustained utilization of skills acquired during treatment. For
this purpose, TIMT works to help participants identify activities
that they have found helpful and systematically integrate these
into their daily life routines. Because TIMT aims to enhance
whatever strategy patients experienced as helpful, it can be used
to maintain treatment outcome regardless of which
psychopathology the patient is suffering from and regardless
of the kind of treatment the patient received before. TIMT
consists of 5 core components. The first component is the
generation of a personal development plan. This process is
conducted during the last 10 days of inpatient treatment in which
TIMT participants complete 3 sessions of blended (face-to-face
and online) standardized goal-setting and action planning instead
of inpatient TAU. Participants develop a detailed plan including
(1) highly relevant personal goals they want to achieve during
the intervention phase, and (2) implementation intentions [41],
including details on how and when they will achieve these goals.
The second and central component of TIMT is the completion
of a structured Web diary in which participants evaluate the
realization of their personal goals weekly and set specific goals
for the next week. The third component of TIMT is an online
peer support group. Subgroups consisting of 3 to 6 participants
are asked to give asynchronous online feedback to one another
on their Web diaries. The fourth component of TIMT is coach
support, involving weekly asynchronous written online feedback
from a therapist regarding a participants’ Web diary. Coaches
differed in their level of formal training, ranging from master’s
level psychology students (n=1) and psychotherapists-in-training
(n=1) to experienced CBT-trained psychotherapists with more
than 10 years of professional experience (n=3). Coaches were
supervised once a week by a licensed senior therapist, as is usual
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in the study hospital. Coaches were advised not to spend more
than 30 minutes per week on support per patient. Total duration
of support rendered was 231 minutes on average per patient
(range: 10-490, SD 128). Finally, TIMT included weekly online
monitoring of psychopathological symptoms.
Treatment Received
The intervention and control group did not differ in types of
treatment received except for frequency of sedatives taken.
Participants in the intervention group were less likely to take
sedatives than controls (P<.001) [15].
Measures
Moderators
In total, we included 11 pretreatment participant characteristics:
age, sex, education, main diagnosis, comorbid personality
disorder, remission status at the end of inpatient treatment,
reliable change in the primary outcome during inpatient
treatment, years since first disorder onset, Internet/computer
literacy, positive outcome expectations, and health-related
self-efficacy.
Information on sex, age, and education were extracted from the
inpatient clinic patient files. All self-report data were assessed
using an online-based assessment tool. Diagnoses and year of
first disorder onsets were assessed during the intake interview.
All interviewers were experienced psychotherapists who were
either psychologists or physicians with a master’s degree or
higher, trained extensively in administering the structured
clinical interviews of the German version of the Diagnostic and
Statistical Manual of Mental Disorders (Fourth Edition)
(DSM-IV) [42]. Participants were classified as being remitted
at inpatient discharge (yes/no) when individual scores in
psychopathological symptom severity (primary outcome
measure as described subsequently) exceeded a raw score value
of 0.685 [43]). Reliable change in symptom severity (yes/no)
was determined according to the widely used reliable change
index of Jacobson and Truax [44]. Individual reliable change
scores less than -1.96 were considered to reflect reliable
(positive) change; scores equal to or greater than -1.96 reflected
no reliable change. Participants were classified as
Internet/computer illiterate if they checked the not at all response
category for the item “I am used to sending and receiving
emails” (1=not at all; 4=completely true). All other participants
were classified as Internet/computer literate. Participants were
coded as having a low education level if they reported 9 years
of school education, as a medium education level if they reported
10 years of school education and a corresponding degree, or as
a high education level if they reported a minimum of 13 years
of school/college education and a corresponding degree.
Positive outcome expectations were assessed by using the
respective subscale of the Patient Questionnaire on Therapy
Expectation and Evaluation (PATHEV) [45]. This scale consists
of 4 items measuring participants’ expectations regarding the
effectiveness of their inpatient treatment (eg, “I think that finally
my problems will be solved”). Response scales ranged from 0
(=do not agree) to 4 (=agree completely). Higher scores reflect
higher positive outcome expectations. Construct validity of the
scale was demonstrated in several studies [45]. In the present
study, internal consistency (Cronbach alpha) was .77.
Health-related self-efficacy was assessed by using the
self-efficacy subscale of the 49-item short form of the Hamburg
Modules for the Assessment of Psychosocial Health
(HEALTH-49) questionnaire [43].This scale includes 5 items
measuring expected persistence and success in several domains
(eg, “Despite my discomfort, I achieve the personal goals that
I set for myself” score inverted for scale calculation; 0=not true,
4=very true). Higher scores denote lower self-efficacy. Internal
consistency (Cronbach alpha) was .86 in the present study.
Dependent Variable
The primary outcome from the effectiveness trial was change
in general psychopathological symptom severity (symptom
severity) from discharge (T2) to 3- and 12-month follow-ups
(T3, T4). Symptom severity was assessed by using the
HEALTH-49, a widely used measure of symptom severity in
Germany [43]. The HEALTH-49 general psychopathological
symptom severity scale consists of 18 items related to
somatoform complaints (7 items), depressiveness (6 items), and
phobic anxiety (5 items). Participants were asked to rate the
severity to which they had suffered from the presented
symptoms in the previous 2 weeks (0=not at all; 4=very much).
Reliability and construct validity have been established in
several studies based on large clinical and nonclinical samples
(1548 psychotherapy inpatients, 5630 primary care patients, see
[43]). In the present study, internal consistency (Cronbach alpha
coefficients) at baseline was .87 for the overall general
psychopathological symptom severity score, 0.90 for depressive
symptoms, 0.86 for somatoform complaints, and 0.86 for phobic
anxiety.
Statistical Analyses
Group differences regarding baseline characteristics were
compared via chi-square tests for categorical variables and t
tests for continuous variables. Interactions between pretreatment
participant characteristics (moderators) and interindividual
differences in intraindividual changes across measurement
occasions were modeled and tested via multilevel mixed-effect
models. Change in symptom severity over time was dummy
coded and treated as a fixed level-1 (ie, within-subjects) effect
(dummy 1: T1-T2, dummy 2: T2-T3, dummy 3: T2-T4).
Treatment conditions (0=control condition, 1=intervention
condition) was treated as a fixed level-2 (ie, between-subjects)
effect. More important for the present purpose, interactions
between moderator and treatment condition, all cross-level
interaction effects (condition × T1-T2, T2-T3, T2-T4; moderator
× T1-T2, T2-T3, T2-T4), and 3-way interaction effects
(moderator × condition × T1-T2, T2-T3, T2-T4) were also
included in the models. A 3-way interaction effect of moderator
× condition × T2-T3 or moderator × condition × T2-T4 would
indicate that the magnitude of the intervention effect varies as
a function of the moderator. The model imposed no restrictions
on the covariance matrix for measurement occasions. Thus, no
model assumptions were tested. We standardized continuous
predictors so that regression coefficients were estimated for
participants with average scores on the putative moderator.
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To increase interpretability and allow for testing nonlinear
effects, categorical variables with more than 2 categories (ie,
diagnosis, years since first disorder onset, education) were
recoded into a maximum of 3 meaningful categories. Because
of low prevalence rates, we excluded diagnoses other than
depression, anxiety disorders, and adjustment disorders. All
continuous moderators (ie, age, self-efficacy, positive outcome
expectations) were standardized so that regression coefficients
refer to participants with average scores on each moderator.
Aiming at an intention-to-treat (ITT) design, we included all
participants randomly assigned to conditions. We employed a
full information maximum likelihood (FIML) estimation, which
allows for all available data to be included without replacement
or imputation of missing values. The FIML estimation for mixed
models is especially robust with respect to missing data [46].
Additionally, we conducted follow-up simple slope analyses
for each significant 3-way interaction effect [47] to probe the
relevant lower-order effects. In this method, the slope and the
significance of the intervention main effect is evaluated for
conditional values of the moderator. For significant 3-way
interactions of continuous moderators, simple slopes were
calculated for the mean and one standard deviation above and
below the mean [48].
Effect sizes for each significant moderator were calculated based
on comparing the effect of control versus intervention groups
on symptom severity scores, with participants grouped by the
significant moderator variable. Cohen’s d scores [49] were
calculated by standardizing the differences between baseline
and follow-up by the pooled standard deviation of baseline
scores.
To verify whether the results of the ITT analyses would be
sustained among the intervention completers sample only, we
subsequently repeated all mixed-effects models with participants
who stayed within key treatment parameters (completed at least
6 of 12 Web diary entries or more than 25 posts, n=177).
To clarify the generalizability of our findings, we assessed all
potential moderators also from patients who were treated during
the recruitment period in the study center, but did not participate
in the trial (not invited, declined to participate, not fulfilling
inclusion criteria) but gave informed consent to use their data
for research purposes (n=1789). Study participants and
nonparticipants were compared using chi-square tests for
categorical variables and t tests for continuous variables.
Finally, if a significant moderator effect contradicted our a priori
expectations, we conducted post hoc simple slope analyses for
the control and intervention groups separately to identify the
reasons for the effect. All analyses were performed with SPSS
19 (IBM Corp, Armonk, NY, USA).
Descriptive Data
Table 1 shows descriptive statistics for the dependent variable
general psychopathological symptom severity. Table 2 shows
descriptive data for all moderator variables. Table 1 and parts
of Table 2 have been reported in previous studies [15].
Consistent with random assignment, no differences were found
between intervention and control group on any of the
pretreatment variables.
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Figure 1. Participant flow and study dropouts at each stage of the study.
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Table 1. Descriptives for primary trial main outcome, psychopathological symptom severity as measured by the general psychopathological symptom
severity subscale of the HEALTH-49 questionnaire.
Control
(n=200)
Intervention
(n=200)
Time of AssessmentAssessment points
SDMeanSDMean
0.711.490.691.50Inpatient admissionT1
0.660.830.640.83Inpatient dischargeT2
0.690.960.610.713-month follow-upT3
0.841.120.690.7812-month follow-upT4
Table 2. Descriptives for pretreatment moderator variables.
Nonparticipantsa
(n=1789)
Control
(n=200)
Intervention
(n=200)Variables
47.12 (9.45)45.45 (9.80)45.09 (8.88)Age, mean (SD)
1360 (76.0)151 (75.5)147 (73.5)Sex (female), n (%)
Education, n (%)
498 (27.8)78 (39.0)80 (40.0)High
779 (43.5)91 (45.5)93 (46.5)Medium
509 (28.5)31 (15.5)26 (13.0)Low
1132 (67.5)b167 (83.5)178 (89.0)Existing Internet literacy (%)
Disorder, n (%)
918 (51.3)113 (56.5)108 (54.0)Mood disorder
206 (11.5)18 (9.0)19 (9.5)Anxiety
405 (22.6)38 (19.0)53 (26.5)Adjustment
260 (14.5)31 (15.5)20 (10.0)Other
175 (9.8)22 (11.0)20 (10.0)Comorbid personality disorder, n (%)
Years since first disorder onset (years) n (%)
430 (24.2)47 (23.5)44 (22.0)< 1
444 (24.9)44 (22.0)55 (27.5)1-5
906 (50.9)105 (52.5)96 (48.0)> 5
1052 (58.8)90 (45.0)100 (50.0)Reliable change during inpatient treatment, n (%)
787 (44.0)93 (46.5)94 (47.0)Remission at discharge, n (%)
1.58 (0.90)1.49 (0.87)1.47 (0.83)Self-efficacy, mean (SD)
3.72 (0.78)3.92 (0.66)3.86 (0.74)Positive outcome expectations, mean (SD)
aAll differences between conditions were nonsignificant. If percentages do not reach 100, it is due to missing data.
bn=1676.
Results
Moderators of Treatment Outcome
Overview
The subsequent tables show the mixed-effect model results
based on ITT for the interactions between pretreatment
participant characteristics (moderators), intervention condition,
and changes in symptom severity. Intercepts represent the
estimated level of symptom severity at baseline (discharge, T2).
The regression coefficient of the moderator represents
differences in symptom severity between participants differing
in 1 unit of the hypothesized moderator at baseline. The
regression coefficient of T1-T2 represents the average difference
in symptom severity between inpatient admission (T1) and
inpatient discharge (T2) in the control group, the regression
coefficient of T2-T3 represents the average difference in
symptom severity between discharge (T2) and 3-month
follow-up (T3) in the control group, and the regression
coefficient of T2-T4 represents the average difference in
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symptom severity between discharge (T2) and 1-year follow-up
(T4) in the control group. The regression coefficient of the
condition represents differences in symptom severity between
the intervention and the control condition at discharge (T2).
The cross-level interactions condition × T1-T2, T2-T3, T2-T4
represent intervention versus control group differences in
changes over time.
As expected, we found (1) a significant decrease in symptom
severity between T1 and T2 in both conditions (T1-T2), (2) no
interaction between T1-T2 and the intervention condition, (3)
a significant condition × T2-T3 interaction effect showing that
symptom severity remained low in the intervention group
between T2 and T3 but increased in the control group, and (4)
a significant T2-T4 × condition interaction effect showing that
symptom severity remained low in the intervention group
between T2 and T4 but increased in the control group (Table
4). The regression coefficients of the moderator × T1-T2, T2-T3,
T2-T4 interaction effects represent moderator effects on changes
in symptom severity across measurement occasions. Finally,
the regression coefficient of condition × moderator × T1-T2,
T2-T3, T2-T4 interaction effects represent moderator effects
on intervention versus control condition differences on change
scores over time.
Dichotomous Moderator Variables
Table 3 shows results for dichotomous moderator variables.
The results revealed no moderator effects on intervention versus
control group differences on changes in symptom severity over
time (see Table 3, condition × moderator × T1-T2, T2-T3,
T2-T4). Thus, none of the dichotomous moderators reliably
altered the effectiveness of intervention versus control on
symptom severity over time. The intervention was superior to
control with regard to outcome sustainability, irrespective of
sex, Internet literacy, reliable changes during inpatient treatment,
comorbid personality disorder, or remission status at T2.
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Table 3. Multilevel results of the interactions between pretreatment participant characteristics (dichotomic moderator variables), intervention condition,
and change in psychopathological symptom severity (dummy coded) for the intention-to-treat sample (N=400) using full maximum likelihood estimation.
Remission statuseComorbid PDdReliable changecInternet literacybSexaInteraction terms
PSEBPSEBPSEBPSEBPSEB
<.0010.040.30<.0010.050.78<.0010.060.98<.0010.110.91<.0010.090.94Interceptf
<.0010.060.98.0040.150.42<.0010.09–0.34.390.12–0.11.130.11–0.16Moderator
<.0010.060.84<.0010.040.66<.0010.030.25<.0010.100.69<.0010.080.60T1-T2 (dummy 1)g
<.0010.050.36<.0010.040.16.990.050.00.040.090.19.0080.080.20T2-T3 (dummy 2)h
<.0010.070.44<.0010.050.30.050.060.12.0010.120.40<.0010.100.48T2-T4 (dummy 3)i
.900.060.01.780.070.02.580.090.05.480.18–0.13.0060.13–0.35Conditionj
.610.08–0.04.530.060.04.250.05–0.06.660.160.07.7500.120.04Condition×T1-T2
<.0010.07–0.30<.0010.06–0.24.0020.07–0.22.040.14–0.30.030.11–0.24Condition×T2-T3
.0020.10–0.30<.0010.07–0.34<.0010.10–0.41<.0010.18–0.65.0010.14–0.45Condition×T2-T4
<.0010.08–0.31.870.130.02<.0010.050.92.800.11–0.03.350.100.09Moderator×T1-T2
<.0010.07–0.37.750.120.04<.0010.070.36.830.10–0.02.610.09–0.04Moderator×T2-T3
.010.10–0.25.610.160.08<.0010.090.41.410.13–0.11.050.11–0.22Moderator×T2-T4
.830.09–0.02.280.21–0.23.570.13–0.07.470.190.14.0020.150.46Condition×moderator
.360.120.11.200.19–0.25.470.070.05.720.17–0.06.840.14–0.03Cond×mod×T1-T2k
.220.100.12.490.18–0.12.460.10–0.08.710.150.06.890.12–0.02Cond×mod×T2-T3k
.410.14–0.11.340.23–0.22.670.140.06.090.200.34.470.160.12Cond×mod×T2-T4k
aSex (0=female; 1=male).
bExisting Internet literacy (0=no; 1=yes).
cReliable change: reliable change during inpatient treatment (0=no; 1=yes).
dComorbid PD: comorbid personality disorder (0=no; 1=yes).
eRemission status: remission status at baseline (T2) (0=in remission; 1=not in remission).
fIntercept: general psychopathological symptom severity in control at baseline (T2).
gT1-T2: dummy-coded change in general psychopathological symptom severity from T1 to T2.
hT2-T3: dummy-coded change in general psychopathological symptom severity from T2 to T3.
iT2-T4: dummy-coded change in general psychopathological symptom severity from T2 to T4.
jCondition (0=control; 1=intervention).
kCond × mod: condition × moderator.
Trichotomous Moderator Variables
Table 4 shows mixed-effects model results for the 3
trichotomous moderator variables education level, diagnoses,
and years since first disorder onset. Three significant 3-way
interaction effects were found. Education dummy 2 (low vs
high education) interacted with condition × T2-T3, and with
condition × T2-T4. These interactions indicate that a greater
intervention effect was found among participants with low
compared to high education level (see Figure 2). Participants
low in education showed a larger intervention vs control
condition difference on changes in symptom severity between
discharge and 3-month follow-up and between discharge and
1-year follow-up. Post hoc analyses demonstrated that although
simple slopes for the intervention main effects (condition ×
T2-T3, T2-T4) were lower among high-educated participants
compared to low-educated participants, the intervention main
effect was still significant (simple slope high-educated
participants T2-T3: B=–0.17, SE 0.08, P=.04; T2-T4: B=–0.25,
SE 0.11, P=.03; simple slope low-educated participants T2-T3:
B=–0.49, SE 0.14, P<.001; T2-T4: B=–0.66, SE 0.18, P<.001).
Moreover, diagnoses dummy 1 (mood disorders vs anxiety
disorders) interacted with condition × T2-T3. Participants
diagnosed with an anxiety disorder showed a larger intervention
versus control group difference on changes in symptom severity
between discharge and 3-month follow-up than participants
diagnosed with a mood disorder (see Figure 3). Post hoc
analyses demonstrate that although simple slopes for the
intervention main effect (condition × T2-T3) were lower among
participants with a mood disorder compared to participants with
an anxiety disorder, the intervention main effect was significant
in both groups (simple slope mood disorder T2-T3: B=–0.21,
SE 0.07, P=.004; simple slope anxiety disorder T2-T3: B=–0.64,
SE 0.02, P<.001). Diagnoses dummy 1 did not moderate the
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association between treatment and change in symptom severity
from discharge to 1-year follow-up.
Years since disorder onset did not moderate the effect of
treatment on any intervention versus control group differences
on change scores. Thus, transdiagnostic Internet-based
maintenance treatment is effective irrespective of years since
first disorder onset.
Figure 2. Estimated course of symptoms based on simple slope mixed-effect model analysis for significant moderators effect of education (0=high
education, n=159; 1=low education, n=57) at inpatient admission (T1), inpatient discharge/begin transdiagnostic Internet-based maintenance treatment
(T2), 3-month follow-up/end transdiagnostic Internet-based maintenance treatment (T3), and 12-month follow-up (T4).
Figure 3. Estimated course of symptoms based on simple slope mixed-effect model analyses for significant moderator effect of diagnoses (0=mood
disorder, n=221; 1=anxiety disorder, n=37) at inpatient admission (T1), inpatient discharge/begin transdiagnostic Internet-based maintenance treatment
(T2), 3-month follow-up/end transdiagnostic Internet-based maintenance treatment (T3), and 12-month follow-up (T4).
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Table 4. Multilevel results for interactions between pretreatment participant characteristics (trichotomous moderator variables), intervention condition,
and change in psychopathological symptom severity (dummy coded) for the intention-to-treat sample (N=400) using full maximum likelihood estimation.
Years since onsetcDiagnosesbEducation levelaInteraction terms
PSEBPSEBPSEB
<.0010.090.88<.0010.060.87<.0010.070.88Interceptd
.6870.11–0.04.0050.160.44.110.10–0.16Moderator dummy 1
.3130.13–0.13.0040.12–0.34.550.140.08Moderator dummy 2
<.0010.090.64<.0010.060.73<.0010.070.63T1-T2e
.180.080.10.0020.050.16.0050.060.17T2-T3f
.0020.100.31<.0010.060.36.0040.080.22T2-T4g
.020.13–0.28.820.08–0.02.170.10–0.14Conditionh
.430.120.09.850.08–0.02.760.090.03Condition×T1-T2
.060.10–0.20.0040.07–0.21.040.08–0.17Condition×T2-T3
.020.14–0.33<.0010.09–0.38.030.11–0.25Condition×T2-T4
.700.11–0.04.800.15–0.04.720.090.03Moderator dummy 1×T1-T2
.680.090.04.890.150.02.640.08–0.04Moderator dummy 1×T2-T3
.800.12–0.03.960.190.01.480.110.07Moderator dummy 1×T2-T4
.100.120.20.400.11–0.09.170.130.17Moderator dummy 2×T1-T2
.190.110.14.750.100.03.350.110.10Moderator dummy 2×T2-T3
.880.140.02.140.13–0.19.020.140.35Moderator dummy 2×T2-T4
.020.150.36.740.22–0.07.110.140.22Cond×mod×dummy 1i
.130.180.27.630.160.08.340.200.19Cond×mod×dummy 2i
.630.15–0.07.750.22–0.07.820.13–0.03Cond×mod×dummy 1×T1-T2i
.820.13–0.03.040.21–0.43.500.11–0.08Cond×mod×dummy 1×T2-T3i
.930.170.01.370.26–0.24.420.15–0.12Cond×mod×dummy 1×T2-T4i
.430.17–0.14.520.150.10.770.180.05Cond×mod×dummy 2×T1-T2i
.560.15–0.09.830.14–0.03.0490.16–0.32Cond×mod×dummy 2×T2-T3i
.890.190.03.410.180.15.0490.21–0.42Cond×mod×dummy 2×T2-T4i
aEducation level dummy 1 (0=high education level; 1=medium education level), education level dummy 2 (0=high education level; 1=low education
level).
bDiagnoses dummy 1 (0=mood disorder; 1=anxiety disorder), diagnoses dummy 2 (0=mood disorder; 1=adjustment disorder).
cYears since onset: years since disorder onset dummy 1 (0=1-5 years; 1=>5 years), years since disorder onset dummy 2 (0=1-5 years; 1=<1 year).
dIntercept: general psychopathological symptom severity in control at baseline (T2).
eT1-T2: dummy-coded change in general psychopathological symptom severity from T1 to T2.
fT2-T3: dummy-coded change in general psychopathological symptom severity from T2 to T3.
gT2-T4: dummy-coded change in general psychopathological symptom severity from T2 to T4.
hCondition (0=control; 1=intervention).
iCond × mod × dummy: condition × moderator × dummy.
Continuous Moderator Variables
Table 5 shows mixed-effect model results for the continuous
moderator variables age, self-efficacy, and positive outcome
expectations. One significant 3-way interaction was found.
Positive outcome expectations interacted with condition ×
T2-T3. This interaction indicates that more positive outcome
expectations were associated with stronger intervention effects
between discharge and 3-month follow-up (see Figure 4).
Follow-up analyses revealed that although simple slopes for the
intervention main effect (condition × T2-T3) were lower among
participants with a moderate (mean) positive outcome
expectation than for participants with a high (mean + 1 SD)
positive outcome expectations, the intervention effect was still
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significant (simple slope moderate positive outcome
expectations T2-T3: B=–0.25, SE 0.05, P<.001; simple slope
high positive outcome expectations T2-T3: B=–0.36, SE 0.07,
P<.001). For participants with a low positive outcome
expectations (mean – 1 SD), the simple slope for the intervention
main effect (condition × T2-T3) was lower and no longer
significant (simple slope low positive outcome expectations
T2-T3: B=–0.13, SE 0.07, P=.09). Only 14.4% of participants
(57/400) expressed low positive outcome expectations.
Therefore, the drop to nonsignificance was likely because of
low power. Moreover, simple slope analyses for this participant
group showed that the intervention main effect on change in
symptom severity from discharge to 1-year follow-up was
significant (simple slope low positive outcome expectations
T2-T4: B=–0.38, SE 0.10, P<.001). Although short-term effects
were not significant, participants with low positive outcome
expectations benefited in the long term from the intervention.
There was no interaction between positive outcome expectations
and change in symptom severity from discharge to 1-year
follow-up and no interaction effect including the other
continuous variables age and self-efficacy. Thus, TIMT seems
to be effective irrespective of age and self-efficacy.
Table 5. Multilevel results for interactions between pretreatment participant characteristics (continuous moderator variables), intervention condition,
and change in psychopathological symptom severity (dummy coded) for intention-to-treat sample (N=400) using full maximum likelihood estimation.
Positive outcome expectationsaSelf efficacyaAgeaInteraction terms
PSEBPSEBPSEB
<.0010.040.84<.0010.040.82.<0010.050.83Interceptb
<.0010.05–0.23<.0010.030.44.0040.04–0.12Moderatorc
<.0010.040.66<.0010.040.67<.0010.040.67T1-T2d
<.0010.040.16<.0010.040.17<.0010.040.17T2-T3e
<.0010.050.30<.0010.050.31<.0010.050.31T2-T4f
.840.06–0.01.890.050.01.850.06–0.01Conditiong
.750.060.02.880.060.01.790.060.02Condition×T1-T2
<.0010.05–0.25<.0010.05–0.25<.0010.05–0.24Condition×T2-T3
<.0010.07–0.35<.0010.07–0.36<.0010.07–0.35Condition×T2-T4
.080.040.08<.0010.04–0.18.790.040.01Moderator×T1-T2
.080.040.07.0020.04–0.16.070.040.07Moderator×T2-T3
.620.050.03.260.05–0.05.260.050.05Moderator×T2-T4
.060.060.12.420.05–0.04.600.060.03Condition×moderator
.090.06–0.10.390.060.05.600.060.03Condition×moderator×T1-T2
.020.05–0.12.220.050.07.500.050.04Condition×moderator×T2-T3
.650.070.03.150.07–0.10.980.070.00Condition×moderator×T2-T4
aAll continuous variables standardized.
bIntercept: general psychopathological symptom severity in control at baseline (T2).
cModerators (0=mean; 1=mean + 1 SD).
dT1-T2: dummy-coded change in general psychopathological symptom severity from T1 to T2.
eT2-T3: dummy-coded change in general psychopathological symptom severity from T2 to T3.
fT2-T4: dummy-coded change in general psychopathological symptom severity from T2 to T4.
gCondition (0=control; 1=intervention).
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Figure 4. Estimated course of symptoms based on simple slope mixed-effect model analyses for significant moderator positive outcome expectations
(mean vs mean – 1 SD vs mean + 1 SD) at inpatient admission (T1), inpatient discharge/begin transdiagnostic Internet-based maintenance treatment
(T2), 3-month follow-up/end transdiagnostic Internet-based maintenance treatment (T3), and 12-month follow-up (T4).
Effect Sizes
Effect sizes (Cohen’s d) for each significant moderator were
calculated based on comparing the effect of control versus
intervention condition on symptom severity, with participants
grouped by parameter values on each significant moderator
variable. A mean effect size of d=0.22 was found for participants
with high education and d=0.80 for participants with low
education for control versus intervention group differences in
change of psychopathological symptom severity from discharge
to 3-month follow-up. For change from discharge to 1-year
follow-up, a mean effect size of d=0.30 for high-educated
participants and a mean effect size of d=0.57 for low-educated
participants was found. With diagnoses as the moderator, control
versus intervention group differences in change from discharge
to 3-month follow-up were d=0.33 for participants with a mood
disorder and d=1.02 for participants with an anxiety disorder.
With positive outcome expectations as moderator, control versus
intervention group differences in change from discharge to
3-month follow-up were d=0.58 for participants with high
positive outcome expectations, d=0.39 for participants with
mean positive outcome expectations, and d=0.20 for participants
with low positive outcome expectations.
Intervention Completers Sample
The results of the following intervention completers analyses
closely paralleled those of the ITT analyses. Most of the
significant 3-way interactions were also significant in the
completers sample (B=–0.45 to –0.12, SE 0.05-0.21,
P=.03-.046). Only the interaction of education dummy 2 with
condition × T2-T4 was no longer significant at follow-up
(B=–0.43, SE 0.22, P=0.05). None of the nonsignificant
interactions in the ITT analyses was significant in the completers
sample (B=–0.11 to 0.02, SE 0.07-0.20, P=.08-.97).
Generalizability
As shown in Table 1 and partly reported in previous studies
[15], study participants did not differ from nonparticipants
(n=1789) regarding sex (χ21=0.4, P=.52), years since first
disorder onset (χ22=0.1, P=.93), existing comorbid personality
disorder (χ21=0.5, P=.46), or remission status at the end of
inpatient treatment (χ21=1.0, P=.32) or initial psychopathological
symptom severity at inpatient admission (study participant
symptom severity T1: mean 1.49, SD 0.70; nonparticipant
symptom severity T1: mean 1.52, SD 0.84, t679.03=–0.69, P=.54).
Study participants were significantly younger than
nonparticipants (with an average difference of 1.7 years,
t2135=–3.54, P<.001), had higher self-efficacy (t2182=–2.11,
P=.04, d=0.15) had a slightly higher education level (χ22=40.81,
P<.001, Kendall’s tau coefficient=0.11), had higher positive
outcome expectations (t625.6=4.07, P<.001, d=0.27). Compared
to nonparticipants, a greater percentage of participants had
access to the Internet (χ21=47.3, P<.001, phi coefficient=0.15)
were Internet literate (χ21=62.7, P<.001, phi coefficient=0.17),
and relatively fewer showed reliable change during inpatient
treatment (χ21=5.3, P=.02, phi coefficient=0.05).
Post Hoc Analyses
The moderator effect of education contradicted our a priori
expectation of higher educated participants benefiting to a
greater extent from the Internet-based intervention than lower
educated participants. Thus, we conducted further post hoc
simple slope analyses for the control group and the intervention
group separately to identify possible explanations for this effect.
For participants in the control group, we found no significant
interaction between education and changes in symptom severity
from discharge to 3-month follow-up (education dummy 2 ×
T2-T3 interaction, B=0.10, SE 0.11, P=.35), but we found a
significant interaction between education and changes from
discharge to 12-month follow-up (education dummy 2 × T2-T4,
B=0.35, SE 0.14, P=.02). Less-educated participants had a
greater risk for deterioration from discharge to 1-year follow-up
than more-educated participants did. In contrast, we found no
significant interaction of low compared to high education level
in the intervention group, neither for changes in symptom
severity from discharge to 3-month follow-up (B=0.21, SE 0.17,
P=.07) nor for changes from discharge to 12-month follow-up
(B=0.06, SE 0.15, P=.68). In contrast to the control group,
less-educated intervention participants did not show a greater
risk for deterioration in symptom severity than more-educated
participants, indicating that participating in TIMT can effectively
reduce this risk factor.
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Discussion
Principal Results and Comparison With Prior Work
In the present study, we aimed to identify moderators of
treatment outcome for TIMT following inpatient psychotherapy.
Education level, positive outcome expectations, and mental
health diagnoses were identified as significant moderators of
TIMT’s effects on psychopathological symptom severity.
Findings indicate that the effects of TIMT on general
psychopathological symptom severity were more pronounced
among participants with a low (vs high) education level.
Participants with high positive outcome expectations profited
in the short term (until 3-month follow-up) more than
participants with low positive outcome expectations. However,
this effect was not significant at 1-year follow-up. Moreover,
participants with a mood disorder benefited less from the
intervention than did participants with an anxiety disorder;
however, this effect was also not significant at 1-year follow-up.
Simple slope analyses revealed that even when some groups
profited less from participating, treatment effects in these
subgroups were still significant, except for the subgroup of
participants with low positive outcome expectation at 3-month
follow-up.
Other pretreatment variables did not interact with TIMT’s effects
indicating that TIMT might be superior to TAU only with regard
to outcome sustainability irrespective of age, gender, comorbid
personality disorder, years since disorder onset, self-efficacy,
remission status at the end of inpatient treatment, reliable change
in psychopathological symptom severity during inpatient
treatment, and Internet literacy. However, given that these
analyses were exploratory and the study was not powered to
find small interaction effects, these null findings should be
interpreted with caution.
The finding that participants with low education benefited more
from using TIMT than participants with high education contrasts
with findings from a study investigating moderators in
face-to-face continuation phase psychotherapy in which
education did not interact with treatment outcome [27].
Moreover, the finding is also in contrast to 3 other studies, that
found that high education was associated with a better treatment
outcome in Internet-based intervention studies [23,29,50]. There
are several possible explanations for the contrast between the
current findings and findings from previous studies: First, these
differences can be explained with variances in treatment type
(acute vs maintenance phase; disorder-specific vs
transdiagnostic), different type of acute phase treatment
(outpatient vs inpatient), study population, and design. Second,
it could also be hypothesized that inpatients with low education
might display a higher risk for deterioration after inpatient
discharge than those with high education because of their more
pronounced difficulties with transferring the acquired skills into
their daily life. Therefore, they might profit to a greater extent
from a maintenance intervention than participants with high
education. This assumption is in-line with a risk-reduction model
of continuation phase treatments [8], assuming that such
concepts may effectively reduce an increased risk for relapse
or recurrence because of a nonchangeable vulnerability (eg,
education, genetic predisposition, developmental conditions)
by helping participants to reduce the consequences of such risk
factors. Post hoc simple slope analyses revealed that in this
study the control group of participants with low education were
more likely to deteriorate compared to highly educated
participants, whereas in the intervention group no such
interaction could be found, indicating that participating in TIMT
can effectively reduce this risk factor. Moreover, the inpatient
treatments present the rather unique opportunity to introduce
patients to the online-based intervention face-to-face and to
teach them the necessary skills for using the intervention
successfully. Therefore, 1 possible mechanism responsible for
the findings in studies in which participants with low education
profited less from Internet-based treatments (ie, low Internet
skills) no longer has any effect. However, as this study is 1 of
the first studies investigating moderators of outcomes in
maintenance phase treatments following inpatient
psychotherapy, future studies are clearly needed to further clarify
the moderating role of education for treatment outcome.
On the basis of our data, we can only speculate on possible
explanations as to why participants with anxiety disorder
profited to a greater extent (in the short term) than participants
with depression. These results are consistent with findings
showing that effect sizes are typically larger for Internet
interventions targeting anxiety than interventions targeting
depression. In a review of 26 RCTs, Griffiths and colleagues
[51] found that effect size differences ranged from 0.42 to 0.65
for interventions involving participants with clinically significant
symptoms of depression, and 0.29 to 1.74 for interventions
involving participants with a diagnosed anxiety disorder. Unlike
guidelines for the treatment of depression [52,53], current
guidelines for the treatment of anxiety disorders [1,54] do not
recommend continuation phase psychological treatments
following acute phase psychotherapy. Our findings, however,
suggest that participants with anxiety disorder can benefit from
an Internet-based maintenance treatment following inpatient
psychotherapy. With regard to the subgroup effects for
depression, future studies should try to examine treatment
strategies to improve TIMT’s outcome, especially for this
high-risk group [3]
The significant finding for positive outcome expectancies
regarding change differences from discharge to 3-month
follow-up is consistent with the idea that high expectancies for
change are associated with better treatment outcome [45,55].
However, these change differences turned insignificant at 1-year
follow-up. Therefore, its use as a predictive indicator for
treatment allocation seems limited.
Limitations
To validly interpret the results of this study, several limitations
should be considered. First, as in most moderator studies, the
analyses in this study were exploratory with participants not
being randomized based on potential moderators of interest.
Despite the limitations of this procedure, a growing recognition
among methodologists has developed about its importance for
fostering empirically founded hypotheses to be tested in future
studies before clinical application [21]. Second, additional
unmeasured variables (eg, participants’ genetic markers,
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developmental histories, self-regulation skills, coping strategies,
attribution style, personality traits) may also moderate TIMT’s
effects, which should be considered in subsequent studies. Third,
as in most longitudinal studies, missing values had to be
considered a relevant threat to the validity of the analyses.
However, the adjustment used to address missing data (FIML)
is especially robust with regard to missing data in mixed models
[46]. Fourth, TIMT was a multicomponent intervention (ie,
personal development plan, Web diary, peer support group,
coach support, monitoring). Thus, the extent that the effects of
specific components were moderated by studied variables is
still unclear. Fifth, the sample size did not provide sufficient
power to detect significant findings for potential moderator
variables with subgroups of small sizes. Because of this
limitation, other diagnoses in addition to mood disorder,
adjustment, and anxiety disorders as potential moderating
variables could not be included in the conducted analyses.
Therefore, no generalization can be made for participants with
other diagnoses. Likewise, the sample size did not provide
sufficient power to examine moderators separately for different
diagnostic status or gender. Therefore, it remains unclear
whether moderators of TIMT’s effects vary across subpopulation
(eg, different moderators for male and female or for different
primary diagnoses). Compared with the nonparticipant cohort,
individuals with low education were underrepresented in the
study sample. Thus, the finding that TIMT was especially
effective for participants with a low education level may only
be generalizable to low-educated participants who are interested
in participating in such an intervention. Finally, the sample
included in this study was recruited in only 1 inpatient hospital,
which clearly limits the generalizability of the findings to other
patient populations.
Strengths
Strengths of the study include (1) its large sample size compared
to other studies, (2) a TAU control condition, which allowed
us to specify which participants might and might not benefit
from TIMT compared to treatment provided by routine health
care services, (3) inclusion and exclusion criteria were kept to
a minimum to maximize the ecological validity, and (4)
generalizability of findings was assessed by comparing the
moderator sample with a large sample of participants
representing basically all patients treated in the study site.
Conclusions
Transdiagnostic Internet-based guided self-help interventions
may represent a cost-effective, far-reaching method for
implementing maintenance phase treatments. Findings from the
current study suggest that TIMT following inpatient
psychotherapy helps patients differing in various characteristics
to maintain treatment outcome. It is especially effective for
participants with low education levels. Although some
subgroups were identified as having profited less from the
intervention than others, all subgroups benefited significantly.
Future studies should replicate our results before clinical
application.
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